Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

But the promise of CRISPR technology has yet to be fulfilled. That could change in the coming years, though. Major genomics breakthroughs — and potentially explosive growth for some stocks ...

The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

This report on CRISPR technology offers market predictions through 2029, examining how CRISPR is used across different fields like drug development, agriculture and diagnostics. It also looks at ...

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

BOSTON, Jan. 2, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for CRISPR Technology: Global Markets was valued at $3.4 billion in 2023. This market is expected ...

CRISPR is a gene-editing tool that makes precise DNA changes, advancing drug development, crop improvement, and <a target= ...

BOSTON, Jan. 2, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for CRISPR Technology: Global Markets was valued at $3.4 billion in 2023. This market is expected to ...